Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
2.530
-0.160 (-5.95%)
At close: Feb 18, 2026, 4:00 PM EST
1.960
-0.570 (-22.53%)
After-hours: Feb 18, 2026, 7:59 PM EST

Bluejay Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
132850-
Market Cap Growth
-43.56%78.09%-80.24%-84.67%--
Enterprise Value
-2-3-3-552-
Last Close Price
2.5319.481952.0012156.7781920.00-
PS Ratio
---30.70--
PB Ratio
0.280.470.520.662.45-
P/TBV Ratio
0.310.470.520.662.45-
Debt / Equity Ratio
0.040.040.130.04--3.22
Net Debt / Equity Ratio
-0.79-0.71-0.63-0.83-0.93-0.44
Net Debt / EBITDA Ratio
0.420.570.191.056.18-0.14
Net Debt / FCF Ratio
0.480.500.201.074.34-0.28
Asset Turnover
---0.01--
Quick Ratio
2.685.311.256.1729.900.49
Current Ratio
2.926.051.827.1932.430.57
Return on Equity (ROE)
-126.19%-178.98%-137.90%-58.25%-34.79%-
Return on Assets (ROA)
-65.84%-77.75%-70.09%-33.72%-17.92%-61.45%
Return on Capital Employed (ROCE)
-186.50%-122.60%-332.90%-78.40%-15.80%364.70%
Earnings Yield
-597.04%-286.84%-658.83%-121.58%-6.99%-
FCF Yield
-527.27%-302.03%-596.89%-116.93%-8.80%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q